Kennedy Capital Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-58,119
| Closed | -$2.34M | – | 693 |
|
|
2023
Q2 | $2.34M | Buy |
58,119
+34,239
| +143% | +$1.38M | 0.05% | 430 |
|
|
2023
Q1 | $1.02M | Buy |
23,880
+390
| +2% | +$16.7K | 0.03% | 485 |
|
|
2022
Q4 | $1.13M | Sell |
23,490
-16
| -0.1% | -$768 | 0.03% | 477 |
|
|
2022
Q3 | $884K | Sell |
23,506
-23,676
| -50% | -$890K | 0.03% | 496 |
|
|
2022
Q2 | $1.3M | Buy |
47,182
+844
| +2% | +$23.3K | 0.04% | 447 |
|
|
2022
Q1 | $2.52M | Sell |
46,338
-367
| -0.8% | -$20K | 0.06% | 417 |
|
|
2021
Q4 | $2.73M | Buy |
46,705
+2,918
| +7% | +$171K | 0.06% | 419 |
|
|
2021
Q3 | $1.73M | Sell |
43,787
-679
| -2% | -$26.9K | 0.04% | 482 |
|
|
2021
Q2 | $1.89M | Sell |
44,466
-23,514
| -35% | -$998K | 0.04% | 482 |
|
|
2021
Q1 | $4.18M | Buy |
+67,980
| New | +$4.18M | 0.08% | 408 |
|